This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Zika Vaccine (Emergent BioSolutions)
Emergent BioSolutions, Inc.
Drug Names(s): Zika Vaccine
Description: Emergent BioSolutions is developing a Zika vaccine using a base vaccine candidate provided by the Biomedical Advanced Research and Development Authority (BARDA).
Zika Vaccine (Emergent BioSolutions) News
Pink Sheet Zika Vaccines Might Be Approved By 2020
Additional information available to subscribers only: